F&V Capital Management LLC Raises Position in CVS Health Co. (NYSE:CVS)

F&V Capital Management LLC raised its stake in CVS Health Co. (NYSE:CVS - Free Report) by 5.7% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 143,249 shares of the pharmacy operator's stock after acquiring an additional 7,735 shares during the period. CVS Health makes up about 2.5% of F&V Capital Management LLC's portfolio, making the stock its 23rd biggest holding. F&V Capital Management LLC's holdings in CVS Health were worth $9,705,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Stonebridge Financial Group LLC acquired a new position in shares of CVS Health during the 4th quarter worth $28,000. Hopwood Financial Services Inc. acquired a new position in shares of CVS Health during the 4th quarter worth $29,000. McIlrath & Eck LLC raised its holdings in shares of CVS Health by 32.6% during the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock worth $32,000 after buying an additional 174 shares in the last quarter. MV Capital Management Inc. raised its holdings in shares of CVS Health by 63.9% during the 1st quarter. MV Capital Management Inc. now owns 741 shares of the pharmacy operator's stock worth $50,000 after buying an additional 289 shares in the last quarter. Finally, Financial Perspectives Inc raised its holdings in shares of CVS Health by 137.5% during the 4th quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator's stock worth $36,000 after buying an additional 466 shares in the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

Insider Activity at CVS Health

In other news, Director Guy P. Sansone purchased 1,570 shares of the company's stock in a transaction that occurred on Thursday, June 5th. The shares were acquired at an average cost of $63.70 per share, with a total value of $100,009.00. Following the purchase, the director now owns 12,007 shares in the company, valued at $764,845.90. This represents a 15.04% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 1.22% of the stock is owned by corporate insiders.

CVS Health Trading Up 1.6%

Shares of NYSE CVS traded up $1.07 during trading on Friday, reaching $67.42. The company had a trading volume of 7,560,954 shares, compared to its average volume of 10,981,592. The company's fifty day moving average price is $65.16 and its 200-day moving average price is $60.09. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $72.51. The stock has a market cap of $85.29 billion, a P/E ratio of 18.42, a PEG ratio of 0.98 and a beta of 0.56. The company has a quick ratio of 0.60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, beating analysts' consensus estimates of $1.62 by $0.63. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. The firm had revenue of $94.59 billion for the quarter, compared to analyst estimates of $93.07 billion. During the same quarter in the previous year, the company posted $1.31 EPS. The business's revenue was up 7.0% on a year-over-year basis. As a group, research analysts expect that CVS Health Co. will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd were given a $0.665 dividend. The ex-dividend date was Tuesday, April 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.95%. CVS Health's dividend payout ratio (DPR) is presently 63.48%.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the company. Argus set a $77.00 price target on CVS Health in a report on Tuesday, February 18th. Mizuho boosted their price target on CVS Health from $70.00 to $76.00 and gave the stock an "outperform" rating in a report on Wednesday, April 9th. Leerink Partners upgraded CVS Health from a "market perform" rating to an "outperform" rating and boosted their price objective for the stock from $55.00 to $75.00 in a research report on Thursday, February 13th. Wells Fargo & Company restated an "overweight" rating and set a $84.00 price objective (up previously from $76.00) on shares of CVS Health in a research report on Tuesday, May 6th. Finally, Cowen restated a "buy" rating on shares of CVS Health in a research report on Monday, May 5th. Two research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $74.75.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.